Completed PHASE1 INTERVENTIONAL NCT00000290

Stress Hormones and Human Cocaine Use - 7

Stress Hormones and Human Cocaine Use

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Cocaine

Updated 6 times since 2017 Last updated: Jan 11, 2017 Started: May 31, 1997 Completion: Dec 31, 2001

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00000290, this PHASE1 trial focuses on Cocaine-Related Disorders and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 6 times since 1997, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Nov 2019 — Jan 2021 [monthly]

Completed PHASE1
Jun 2018 — Nov 2019 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

May 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
University of Minnesota

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States